Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease
Open Access
- 29 January 2013
- journal article
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 4 (1), 4-18
- https://doi.org/10.1111/jdi.12042
Abstract
One of the most overlooked of all serious complications of diabetes is cardiovascular autonomic neuropathy. There is now clear evidence that suggests activation of inflammatory cytokines in diabetic patients and that these correlate with abnormalities in sympathovagal balance. Dysfunction of the autonomic system predicts cardiovascular risk and sudden death in patients with type 2 diabetes. It also occurs in prediabetes, providing opportunities for early intervention. Simple tests that can be carried out at the bedside with real‐time output of information – within the scope of the practicing physician – facilitate diagnosis and allow the application of sound strategies for management. The window of opportunity for aggressive control of all the traditional risk factors for cardiovascular events or sudden death with intensification of therapy is with short duration diabetes, the absence of cardiovascular disease and a history of severe hypoglycemic events. To this list we can now add autonomic dysfunction and neuropathy, which have become the most powerful predictors of risk for mortality. It seems prudent that practitioners should be encouraged to become familiar with this information and apply risk stratification in clinical practice. Several agents have become available for the correction of functional defects in the autonomic nervous system, and restoration of autonomic balance is now possible.Keywords
This publication has 68 references indexed in Scilit:
- Autonomic imbalance: prophet of doom or scope for hope?Diabetic Medicine, 2011
- Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and TreatmentsDiabetes Care, 2010
- Neuropathy: The Crystal Ball for Cardiovascular Disease?Diabetes Care, 2010
- Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) TrialDiabetes Care, 2010
- Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup CharacteristicsDiabetes Care, 2010
- Balance Training Reduces Falls Risk in Older Individuals With Type 2 DiabetesDiabetes Care, 2010
- RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunctionProceedings of the National Academy of Sciences of the United States of America, 2009
- Microalbuminuria and Cardiovascular Autonomic Dysfunction Are Independently Associated With Cardiovascular Mortality: Evidence for Distinct PathwaysDiabetes Care, 2009
- Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjectsBrain, Behavior, and Immunity, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesThe New England Journal of Medicine, 2008